Bill

Bill > HR4100


US HR4100

DISARM Act of 2019 Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019


summary

Introduced
07/30/2019
In Committee
07/31/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes. This bill requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.

AI Summary

This bill, the Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019, aims to encourage the development and use of certain antimicrobial drugs. It requires additional payment under Medicare's inpatient prospective payment system for services involving DISARM antimicrobial drugs, which are defined as drugs approved by the FDA, designated as qualified infectious disease products, and have received exclusivity period extensions. The bill also requires the Government Accountability Office to study and report on the barriers to developing such antimicrobial drugs and recommend ways to address those barriers.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (24)

Last Action

Referred to the Subcommittee on Health. (on 07/31/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...